Diabetes screening with hemoglobin A1c prior to a change in guideline recommendations: Prevalence and patient characteristics

BMC Family Practice

Volumn 12, Issue , 2011, Pages

  Greiver, Michelle ^a   Aliarzadeh, Babak ^b   Moineddin, Rahim ^a,c,d   Meaney, Christopher ^a   Ivers, Noah ^c,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b North Toronto Research Network   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD; DIABETES MELLITUS; DRUG POTENTIATION; FEMALE; HUMAN; MALE; MIDDLE AGED; PRACTICE GUIDELINE; PREVALENCE; RETROSPECTIVE STUDY;

ADULT; AGED; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80052029161     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-12-91     Document Type: Article

References (33)

1. Canadian Diabetes Association 2008 Clinical Practice Guidelines for the prevention and management of diabetes in Canada. Canadian Journal of Diabetes 2008 32 supp 1
2. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Harris MI, Klein R, Welborn TA, Knuiman MW, Diabetes Care 1992 15 7 815 819 10.2337/diacare.15.7.815 1516497
3. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2010 33 Supplement 1 62 S69 20042775
4. American Diabetes Association: Standards of Medical Care in Diabetes 2010. Diabetes Care 2010 33 Supplement 1 11 S61 20042772
5. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care 2009 32 7 1327 1334 19502545
6. Standards of Medical Care in Diabetes 2010. Diabetes Care 2010 33 Supplement 1 11 S61 20042772
7. Trends in laboratory testing for diabetes in Ontario, Canada 1995-2005: a population-based study. Wilson SE, Lipscombe LL, Rosella LC, Manuel DG, BMC Health Serv Res 2009 9 41 10.1186/1472-6963-9-41 19250533
8. Short-term Variability in Measures of Glycemia and Implications for the Classification of Diabetes. Selvin E, Crainiceanu CM, Brancati FL, Coresh J, Arch Intern Med 2007 167 14 1545 1551 10.1001/archinte.167.14.1545 17646610 (Pubitemid 47124186)
9. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Bennett CM, Guo M, Dharmage SC, Diabet Med 2007 24 4 333 343 10.1111/j.1464-5491.2007.02106.x 17367307 (Pubitemid 46452406)
10. Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL, N Engl J Med 2010 362 9 800 811 10.1056/NEJMoa0908359 20200384
11. U.S. Preventive Services Task Force. Screening for Type 2 Diabetes Mellitus in Adults: Clinical Summary of U.S. Preventive Services Task Force Recommendation. http://www.ahrq.gov/clinic/uspstf/uspsdiab.htm
12. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ziemer DC, Kolm P, Weintraub WS, Vaccarino V, Rhee MK, Twombly JG, Narayan KM, Koch DD, Phillips LS, Ann Intern Med 2010 152 12 770 777 20547905
13. Building a pan-Canadian primary care sentinel surveillance network: initial development and moving forward. Birtwhistle R, Keshavjee K, Lambert-Lanning A, Godwin M, Greiver M, Manca D, Lagace C, J Am Board Fam Med 2009 22 4 412 422 10.3122/jabfm.2009.04.090081 19587256
14. Update from the Ministry: primary health care and family health teams. Barnes M, Building the Academic into the Academic Family: April 27 2007 2007; Sunnybrook hospital 2007
15. Capitation and enhanced fee-for-service models for primary care reform: a population-based evaluation. Glazier RH, Klein-Geltink J, Kopp A, Sibley LM, CMAJ 2009 180 11 72 81 10.1503/cmaj.081316 19468106
16. The accuracy of age-sex registers, practice medical records and family practitioner committee registers. Fraser RC, Clayton DG, J R Coll Gen Pract 1981 31 228 410 419 7320986
17. Diabetes in Ontario: Determination of prevalence and incidence using a validated administrative data algorithm. Hux JE, Ivis F, Flintoft V, Bica A, Diabetes Care 2002 25 3 512 516 10.2337/diacare.25.3.512 11874939 (Pubitemid 41103345)
18. Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial. Otta CF, Wior M, Iraci GS, Kaplan R, Torres D, Gaido MI, Wyse EP, Gynecol Endocrinol 2010 26 3 173 178 10.3109/09513590903215581 20148739
19. Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women. Raffone E, Rizzo P, Benedetto V, Gynecol Endocrinol 2010 26 4 275 280 10.3109/09513590903366996 20222840
20. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH, Cochrane Database Syst Rev 2009 4 D003053
21. A controlled trial of population management: diabetes mellitus: putting evidence into practice (DM-PEP). Grant RW, Cagliero E, Sullivan CM, Dubey AK, Estey GA, Weil EM, Gesmundo J, Nathan DM, Singer DE, Chueh HC, et al. Diabetes Care 2004 27 10 2299 2305 10.2337/diacare.27.10.2299 15451891 (Pubitemid 39281376)
22. Preventive screening. What factors influence testing? Finkelstein M, Can Fam Physician 2002 48 9 1494 1501 12371308 (Pubitemid 35203711)
23. U.S. Preventive Services Task Force. Screening for Coronary Heart Disease: Recommendation Statement. Ann Intern Med 2004 240
24. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Stone EG, Morton SC, Hulscher ME, Maglione MA, Roth EA, Grimshaw JM, Mittman BS, Rubenstein LV, Rubenstein LZ, Shekelle PG, Ann Intern Med 2002 136 9 641 651 11992299 (Pubitemid 34462676)
25. Preventive care checklist form. Evidence-based tool to improve preventive health care during complete health assessment of adults. Dubey V, Glazier R, Can Fam Physician 2006 52 48 55 16477909 (Pubitemid 43805230)
26. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, Couture P, Dufour R, Fodor G, Francis GA, et al. Can J Cardiol 2009 25 10 567 579 10.1016/S0828-282X(09)70715-9 19812802
27. 2010 Canadian Hypertension Education Program (CHEP) recommendations: the scientific summary-an update of the 2010 theme and the science behind new CHEP recommendations. Campbell NR, Kaczorowski J, Lewanczuk RZ, Feldman R, Poirier L, Kwong MM, Lebel M, McAlister FA, Tobe SW, Canadian Hypertension Education P, Can J Cardiol 2010 26 5 236 240 10.1016/S0828-282X(10)70377-9 20485687
28. Abdominal obesity and metabolic syndrome. Despres JP, Lemieux I, Nature 2006 444 7121 881 887 10.1038/nature05488 17167477 (Pubitemid 46024995)
29. Counseling and Interventions to Prevent Tobacco Use and Tobacco-Caused Disease in Adults and Pregnant Women.
30. Quantifying clinical data quality using relative gold standards. Kahn MG, Eliason BB, Bathurst J, AMIA Annu Symp Proc 2010 356 360
31. Campbell MJ, Statistics at square two London: BMJ Publishing Group 2001
32. Diagnostic value of glycated haemoglobin HbA(1c) for the early detection of diabetes in high-risk subjects. Kim KS, Kim SK, Lee YK, Park SW, Cho YW, Diabet Med 2008 25 8 997 1000 10.1111/j.1464-5491.2008.02489.x 18959616
33. The effectiveness and efficiency of diabetes screening in Ontario, Canada: a population-based cohort study. Wilson S, Rosella L, Lipscombe L, Manuel D, BMC Public Health 2010 10 1 506 10.1186/1471-2458-10-506 20727141